BRO
Brown & Brown, Inc.
BRO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over BRO overall, supported by stronger modeled upside and stronger fundamentals.
BRO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BRO's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRO.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BRO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $70.55 | — |
| Current | 23x | $70.55 | — |
| Cheap | 24x | $75.13 | +6.5% |
| Fair | 28x | $86.99 | +23% |
| Expensive | 30x | $94.46 | +34% |
Historical ranges are pointers, not guarantees.
BRO has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BRO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect BRO's profitability to improve, with its earnings and revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BRO on the outlook, with more favorable earnings and revenue expectations.
BRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.65 | +49% |
| Q3 2026 | $3.12 | -6.6% |
| Q2 2026 | $3.13 | -9.8% |
| Q1 2026 | $3.07 | -14% |
| Q4 2025 | $3.16 | -8.7% |
| Q3 2025 | $3.34 | -8.7% |
| Q2 2025 | $3.47 | 0% |
| Q1 2025 | $3.59 | +11% |
| Q4 2024 | $3.46 | +13% |
BRO earned $3.12 per share over the past year, down 6.6% from the year before. Its recent earnings include one-off gains.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BRO on earnings, with more consistent year-over-year improvement.
BRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +7.4% |
| Q2 2026 | $1.7B | +30% |
| Q1 2026 | $1.9B | +35% |
| Q4 2025 | $1.6B | +36% |
| Q3 2025 | $1.6B | +35% |
| Q2 2025 | $1.3B | +9.1% |
| Q1 2025 | $1.4B | +12% |
| Q4 2024 | $1.2B | +15% |
BRO has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -0.8 points |
| Q2 2026 | 23% | -1.3 points |
| Q1 2026 | 28% | -2.4 points |
| Q4 2025 | 20% | -3.3 points |
| Q3 2025 | 19% | -7.4 points |
| Q2 2025 | 24% | -5.2 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 23% | -11 points |
BRO's operating margin was 19% last quarter, down 0.8 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BRO on profitability, with a higher operating margin.
BRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $493M | +9.1% |
| Q2 2026 | $329M | +6.1% |
| Q1 2026 | $241M | +23% |
| Q4 2025 | $424M | +24% |
| Q3 2025 | $452M | +8.4% |
| Q2 2025 | $310M | -7.2% |
| Q1 2025 | $196M | +$196M |
| Q4 2024 | $341M | +24% |
BRO has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -4M shares |
| 1 year | -0.6% | -2M shares |
| 3 years | +17% | +48.7M shares |
| 5 years | +19% | +53.1M shares |
| Available history | +20% | +55.4M shares |
BRO has 330M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $250M |
| Q2 2026 | $250M |
| Q1 2026 | $250M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $100,000 |
| Q4 2022 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BRO on shareholder dilution, with a more favorable share count trend.
BRO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 4.2x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 4.6x | High |
| Q3 2025 | 4.8x | High |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.3x | Moderate |
BRO has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 69.7 | Neutral |
BRO's weekly RSI is 53 (neutral) and its Stochastic is 70 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BRO PE vs Financial Services Sector
| Metric | BRO | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 74% above |
| PE % | 9 | 63 | 54 pts below |
BRO is trading at 23x earnings, a 74% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over BRO on valuation relative to its sector.
BRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $67.3 | 4.8% above |
| 20 week MA | $68.7 | 2.7% above |
| 50 week MA | $68.6 | 2.8% above |
| 100 week MA | $85.8 | 18% below |
| 200 week MA | $82.8 | 15% below |
BRO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 15% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.3 | $46.3 | +18% |
| 2021 | $46.3 | $68.0 | +47% |
| 2022 | $68.0 | $56.9 | -16% |
| 2023 | $56.9 | $71.1 | +25% |
| 2024 | $71.1 | $102.9 | +45% |
| 2025 | $102.9 | $80.8 | -21% |
| 2026 YTD | $80.8 | $70.6 | -13% |
BRO has finished higher in four of the last six years. It's down 13% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BRO on returns for 2026, with the stronger performance.